文献速递腹部技术与安全US

直接抗病毒药物治疗后丙型肝炎患者的剪切波弹性成像与瞬时弹性成像

Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals.
PubMed 文献 · Radiol Med · 2021-01-25

前瞻性研究纳入22例接受直接抗病毒药物治疗的丙型肝炎患者,在治疗前、治疗结束时及治疗后12、24、48周共5个时间点行点剪切波弹性成像(pSWE)和瞬时弹性成像(TE)测量肝硬度。pSWE测得的肝硬度值随时间显著下降(p=0.02),TE测得的肝硬度值下降无统计学意义(p>0.05)。pSWE可能较TE更能识别肝硬度下降,且与治疗12周持续病毒学应答相关。

要点

  • pSWE在DAA治疗随访中较TE更能识别肝硬度下降。
  • pSWE测得的肝硬度值从治疗前至治疗后48周呈显著下降。
  • TE测得的肝硬度值下降在随访期间无统计学意义。

诊断标准与关键数值

  • pSWE测得的肝硬度值(kPa)在T0(14.3 ± 9.3)、post-Tx(11.8 ± 10.5)、12周(7.5 ± 3.3)、24周(8 ± 3.8)和48周(8.5 ± 4.6)之间差异有统计学意义(p = 0.02)。
  • TE测得的肝硬度值(kPa)在T0(14.7 ± 9.3)、post-Tx(12 ± 9.5)、12周(11.6 ± 7.7)、24周(10.3 ± 6)和48周(10.8 ± 7.5)之间差异无统计学意义(p > 0.05)。
  • 多因素基线分析显示,TE硬度测量与肝硬化、肝静脉血流类型存在显著独立关联。
  • 多因素基线分析显示,delta-pSWE测量(基线与时治疗12个月后硬度测量值之差)与纤维化分期(p = 0.006)及治疗12周持续病毒学应答(SVR12,p = 0.017)存在显著独立关联。

临床应用与阅片要点

  • 在丙型肝炎患者DAA治疗随访中,pSWE可用于评估肝硬度下降,该下降与SVR12相关。
  • TE测得的肝硬度值下降在随访期间无统计学意义。
  • 基线TE硬度测量与肝硬化及肝静脉血流类型存在独立关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the ultrasound (US) and pulse shear wave elastography (pSWE, Elast PQ®) methods with transient elastography (TE), clinical scores and laboratory tests, during the follow-up of HCV patients receiving direct-acting antiviral drugs (DAA).

METHODS: Our prospective study from June 2016 to December 2017 included 22 consecutively enrolled HCV-positive patients (59.7 ± 12.3 years, 11 male) which were subjected to antiviral therapy. All patients underwent B-mode ultrasound, color-Doppler, pSWE and TE five times: before therapy (T0), at the end of therapy (post-Tx), and at 12, 24, 48 weeks post-therapy. The liver stiffness (LS) values obtained with pSWE and TE and the data coming from US assessment and clinical evaluation were compared.

RESULTS: We obtained a statistically significant reduction of LS values (kPa) measured by pSWE, between T0 (14.3 ± 9.3), post-Tx (11.8 ± 10.5), 12 weeks (7.5 ± 3.3), 24 weeks (8 ± 3.8) and 48 weeks (8.5 ± 4.6) (p = 0.02). The reduction of kPa measured by TE was not significant between T0 (14.7 ± 9.3), post-Tx (12 ± 9.5), 12 weeks (11.6 ± 7.7), 24 weeks (10.3 ± 6) and 48 weeks (10.8 ± 7.5) (p > 0.05). Multivariate baseline analysis showed significant independent association among measurement of TE stiffness with cirrhosis, type of vein hepatic flow and showed significant independent association between delta-pSWE measurement (difference between stiffness measurements at the baseline and 12 months after treatment) with staging of fibrosis (p = 0.006) and sustained virologic response after 12 weeks of treatment (SVR12, p = 0.017).

CONCLUSION: The pSWE method has shown better ability than TE to identify a reduction in LS. Therefore, pSWE allow to evaluate stiffness reduction in HCV patient during DAA treatment follow-up, which is related to SVR12.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Argalia G, Tarantino G, Ventura C, et al. Shear wave elastography and transient elastography in HCV patients after direct-acting antivirals. Radiol Med. 2021. PMID: 33492651. doi:10.1007/s11547-020-01326-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。